Funder
China Postdoctoral Science Foundation
National Natural Science Foundation of China
Sichuan University West China Hospital
Reference10 articles.
1. Safety and tolerability of inhalational anticholinergics in COPD;Sharafkhaneh;Drug Healthc Patient Saf,2013
2. The impact of COPD in trends of urinary tract infection hospitalizations in spain, 2001-2018: a population-based study using administrative data;de Miguel-Diez;J Clin Med,2020
3. Efficacy and cardiovascular safety of LAMA in patients with COPD: a systematic review and meta-analysis;Zhang;J Investig Med,2021
4. Combination therapy with long-acting bronchodilators and the risk of major adverse cardiovascular events in patients with COPD: a systematic review and meta-analysis;Yang;Eur Respir J,2023
5. Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis;Halpin;Int J Chron Obstruct Pulmon Dis,2015